Longport

LPTI · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About LPTI

Longport, Inc. engages in the manufacture, development, marketing, and sale of high resolution ultrasound imaging systems. The company is headquartered in Chadds Ford, Pennsylvania and currently employs 8 full-time employees. The firm focuses on high-resolution medical ultrasound. The company focuses on providing imaging systems that help in the prevention, assessment and treatment of medical conditions. The firm offers a high-resolution ultrasound (HRUS) imaging system, EPISCAN I-200, which utilizes ultrasound to image the skin and underlying soft tissue. EPISCAN I-200 can be connected to a range of interchangeable imaging probes that enable the imaging of the skin and underlying soft tissue at frequencies between 20 megahertz (MHz) and 50 MHz. EPISCAN is utilized in a range of clinical applications, as well as in research and development. EPISCAN enables the examination of tissue at a microscopic level. Its technology is used in a range of applications, such as wound assessment and prevention, dermatology, aesthetics, and research, including validation of processes and products that impact the skin.

Employees
8
Headquarters
Chadds Ford, Pennsylvania
Listed
Sep 7, 1994
Sector
Health Care
Industry
Biotechnology

Leadership

Longport executives
NameTitle
Paul Wilson—
Michael Boyd—
Brian Clymer—
Paul Quintavalle—

Similar companies

Companies in the same industry as Longport

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.